2-Dec-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Medicine
Urology
Male Sexual Dysf...
Browse
ALL OF MEDICINE
Urology
Benign Bladder & Urethral Disorders
Benign Prostatic Hyperplasia & Prostatitis
Lower Urinary Tract: Dysfunction, Incontinence & Urodynamics
Male Infertility
Male Sexual Dysfunction
New Technology
Pediatric Urology
Stones & Endourology
Urological Infections
Related Sections
Genitourinary Cancers
Reproductive Endocrinology
Sexual Dysfunction
Sexually Transmitted Diseases (without HIV)
selected for
My F1000 Medicine
Browse > Urology > Male Sexual Dysfunction
Current Top 10 by F1000 Factor
/
All Time Top 10 by F1000 Factor
/
Most viewed
(from all journals)
/
Most viewed
(from specialty journals)
/
Hidden jewels
Page 1 of 3. Select Page:
1
2
3
>>
Display
10
/
20
/
50
papers per page
printer friendly
10 per page
20 per page
50 per page
any date
past 7d
past 14d
past 30d
past 60d
past 90d
past 180d
past 1y
past 2y
past 5y
all papers
hypotheses
new findings
confirmations
tech advances
controversial
refutation
dissenting
new on F1000
newly evaluated
F1000 factor
most evaluations
this page
selected articles
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
Recommended
F1000 Factor
3.0
Confirmation
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L
J Urol
2008 Oct
180
(4):1228-34 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Viorel Bucuras with Razvan Bardan
Evaluated 17 Nov 2008
Recommended
F1000 Factor
3.0
New Finding
Sexual satisfaction in the seventh decade of life.
DeLamater J, Hyde JS, Fong MC
J Sex Marital Ther
2008
34
(5):439-54 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| R. Taylor Segraves
Evaluated 11 Nov 2008
Recommended
F1000 Factor
3.0
Confirmation
Penetrating external genital trauma: a 30-year single institution experience.
Phonsombat S, Master VA, McAninch JW
J Urol
2008 Jul
180
(1):192-5; discussion 195-6 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Kenneth Angermeier with Hadley Wood
Evaluated 10 Nov 2008
Must Read
F1000 Factor
6.0
Confirmation
The chronology of depression and distress in men with Peyronie's disease.
Nelson CJ, Diblasio C, …, Guhring P, Mulhall JP
J Sex Med
2008 Aug
5
(8):1985-90 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Nelson Bennett
Evaluated 30 Sep 2008
Recommended
F1000 Factor
3.0
New Finding
Different testosterone levels are associated with ejaculatory dysfunction.
Corona G, Jannini EA, …, Forti G, Maggi M
J Sex Med
2008 Aug
5
(8):1991-8 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Jacques Buvat
Evaluated 23 Sep 2008
Recommended
F1000 Factor
3.0
Confirmation
New Finding
A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Stief CG, Porst H, …, Beneke M, Ulbrich E
Eur Urol
2008 Jun
53
(6):1236-44 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Stavros Gravas
Evaluated 19 Sep 2008
Recommended
F1000 Factor
3.0
Controversial
Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency.
Allan CA, Forbes EA, Strauss BJ, McLachlan RI
Int J Impot Res
2008 Jul-Aug
20
(4):396-401 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| R. Taylor Segraves
Evaluated 17 Sep 2008
Recommended
F1000 Factor
3.0
Confirmation
Hypothesis
Chronic Dosing of Phosphodiesterase Type 5 Inhibitors
Donatucci CF
Current Sexual Health Reports
2008
5
:65-69
Selected by
| Michael Perelman with Elizabeth Grill
Evaluated 16 Sep 2008
Recommended
F1000 Factor
3.0
Tech Advance
A conditional knockout mouse line of the oxytocin receptor.
Lee HJ, Caldwell HK, …, Tolu SG, Young WS
Endocrinology
2008 Jul
149
(7):3256-63 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Torsten Reinheimer
Evaluated 16 Sep 2008
Recommended
F1000 Factor
3.0
Confirmation
Risk Factors for Emotional and Relationship Problems in Peyronie's Disease.
Smith JF, Walsh TJ, …, Turek P, Lue T
J Sex Med
2008 Jul 14 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Jason Greenfield
Evaluated 8 Sep 2008
top of page
Page 1 of 3. Select Page:
1
2
3
>>
Display
10
/
20
/
50
papers per page
© 2008 Medicine Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info